Form 8-K - Current report:
SEC Accession No. 0001213900-24-107083
Filing Date
2024-12-10
Accepted
2024-12-09 20:10:58
Documents
16
Period of Report
2024-12-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022411101-8k_abprohold.htm   iXBRL 8-K 41785
2 LETTER FROM MARCUM LLP TO THE SECURITIES AND EXCHANGE COMMISSION DATED DECEMBER ea022411101ex16-1_abprohold.htm EX-16.1 2978
7 GRAPHIC ex16-1_001.jpg GRAPHIC 5113
  Complete submission text file 0001213900-24-107083.txt   274437

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abp-20241209.xsd EX-101.SCH 3888
4 XBRL DEFINITION FILE abp-20241209_def.xml EX-101.DEF 26778
5 XBRL LABEL FILE abp-20241209_lab.xml EX-101.LAB 36996
6 XBRL PRESENTATION FILE abp-20241209_pre.xml EX-101.PRE 25402
18 EXTRACTED XBRL INSTANCE DOCUMENT ea022411101-8k_abprohold_htm.xml XML 6053
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241536818
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)